+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevention of sarcoplasmic reticular Ca transport dysfunction in diabetic heart with transgenic human kallikrein expression is not due to altered SERCA2 and phospholamban expression



Prevention of sarcoplasmic reticular Ca transport dysfunction in diabetic heart with transgenic human kallikrein expression is not due to altered SERCA2 and phospholamban expression



Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Suppl.): R29




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035551742

Download citation: RISBibTeXText


Related references

Transgenic expression of human kallikrein prevents sarcoplasmic reticular calcium ion transport dysfunction in diabetic rat heart. Hypertension 36(4): 655, 2000

Cardiac reticular Ca transport and contractility of papillary muscle of transgenic rats overexpressing the sarcoplasmic reticular Ca ATPase SERCA2. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Suppl.): R29, 2000

Transgenic expression of human kallikrein prevents altered left ventricular function, the decline in sarcoplasmic reticulum calcium pump activity and the rise in cardiac collagen content in diabetic rats. Circulation 102(18 Suppl.): II 267, October 31, 2000

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. Faseb Journal 18(7): 828-835, 2004

Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. Faseb Journal 18(15): 1967-1969, 2004

Minimal amount of insulin can reverse diabetic heart function: Sarcoplasmic reticulum Ca2+ transport and phospholamban protein expression. Korean Journal of Physiology & Pharmacology 3(2): 175-182, 1999

Transgenic expression of human kallikrein prevents haemodynamic alterations and decline in sarcoplasmic reticulum calcium pump activity in diabetic rats. European Heart Journal 21(Abstract Suppl.): 3, August-September, 2000

Diabetic alterations in phospholamban protein expression Regulatory effects on sarcoplasmic reticulum Ca-2+ transport. Biophysical Journal 70(2 PART 2): A282, 1996

Doxorubicin induces sarcoplasmic reticulum calcium regulation dysfunction via the decrease of SERCA2 and phospholamban expressions in rats. Cell Biochemistry and Biophysics 70(3): 1791-1798, 2015

Diastolic contractile dysfunction and altered sarcoplasmic reticulum gene expression in cardiac hypertrophy of renin transgenic rats. European Heart Journal 16(ABSTR SUPPL ): 101, 1995

Altered sarcoplasmic reticulum gene expression in cardiac hypertrophy of renin transgenic rats corresponds to diastolic contractile dysfunction. Circulation 92(8 SUPPL ): I348-I349, 1995

Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca-2+-ATPase protein levels: Effects of Ca-2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circulation Research 77(4): 759-764, 1995

Thyroxine-induced alterations in the cardiac function and the expression of sarcoplasmic reticular proteins in phospholamban-deficient mouse hearts. European Heart Journal 17(ABSTR SUPPL ): 329, 1996

Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart. Molecular and Cellular Biochemistry 261(1-2): 245-249, 2004